Browse > Article
http://dx.doi.org/10.5762/KAIS.2017.18.9.123

Mumps meningoencephalitis without parotitis, after secondary vaccination of Measles-Mumps-Rubella (MMR) : A Case Report  

Choi, Pahn Kyu (Department of Neurology, Chosun University School of Medicine)
Kang, Hyun Goo (Department of Neurology, Chosun University School of Medicine)
Publication Information
Journal of the Korea Academia-Industrial cooperation Society / v.18, no.9, 2017 , pp. 123-126 More about this Journal
Abstract
Mumps, which are also known as epidemic parotitis,lead to viral infectious diseases that can cause complication such as pancreatitis, orchitis, hearing impairments, oophoritis, parotitis and meningitis. Central nervous system involvement has been reported in up to 65% of mumps patients, with most of these including meningitis. Meningoencephalitis is a rare central nervous system (CNS) complication of the mumps. Measles-Mumps-Rubella (MMR) vaccination has been reported protective effect against clinical complications and hospitalization. Here, we describe acute mumps meningoencephalitis in a 24-year-old female without parotitis who had received the MMR vaccination by age related schedule. She initially visited our hospital with aggravated cognition and confusion. After conservative viral treatment, she recovered cognitive function rapidly and complication was not remained. We report here a case of a patient with good recovery of mumps meningoencephalitis without parotitis after secondary vaccination for MMR.
Keywords
Confusion; Central nervous system; MMR vaccination; Meningoencephalitis; Parotitis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Koyama S., Morita K., Yamaguchi S., Fujikane T., Sasaki N., Aizawa H., An adult case of mumps brainstem encephalitis. Intern Med, vol. 39, pp. 499-502, 2000. DOI: https://doi.org/10.2169/internalmedicine.39.499   DOI
2 Alfaro A., Granda D., Mumps encephalitis in adulthood. Neurologia 6, pp. 108-110, 1991.
3 Kim M., Ki M., Hu Y., Choi B., An epidemiologic investigation on mumps outbreak in Cheju-do, 1998. Korean J Prev Med, 34, pp. 89-99, 2001.
4 Kim S. S., Han H. W., Go U., Chung H. W., Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity. Vaccine, vol. 23, pp. 290-297, 2004. DOI: https://doi.org/10.1016/j.vaccine.2004.07.030   DOI
5 Galazka A. M., Robertson S. E., Krajgher A., Mumps and mumps vaccine: a global review, Bull World Health Organ, vol. 77, pp. 3-14, 1999.
6 Yung C. F., Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis. vol. 17, no. 4, pp. 661-667, quiz 766, 2011.   DOI
7 Lee J. Y., Kim Y. Y., Shin G. C., Na B. K., Lee J. S., Lee HDl., Molecular characterization of two genotype of mumps virus circulated in Korea during 1998-2001. Virus Res, vol. 97, pp. 111-116, 2003. DOI: https://doi.org/10.1016/j.virusres.2003.08.006   DOI
8 Sonmez F. M., Odemis E, Ahmetoglu A, Ayvaz A. Brainstem encephalitis and acute disseminated encephalomyelitis following mumps, Pediatr Neurol, vol. 30, pp. 132-134, 2004. DOI: https://doi.org/10.1016/j.pediatrneurol.2003.09.004   DOI
9 Sane J., Gouma S., Koopmans M., de Melker H, Swaan C, van Binnendijk R,Hahne S., Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012. Emerg Infect Dis, vol. 20, no. 4, pp. 643-648, 2014. DOI: https://doi.org/10.3201/eid2004.131681   DOI
10 Orlikova H, Maly M, Lexova P, et al. Protective effect of vaccination against mumps complications, Czech Republic, 2007-2012. BMC Public Health, vol. 16, pp. 293, 2016. DOI: https://doi.org/10.1186/s12889-016-2958-4   DOI